Wikipedia -WSS

Wikipedia

author：hotspot 2025-09-30 04:32:08 Page View：9

Johnson & Johnson sign — MARK RALSTON/AFP via Getty Images

WASHINGTON — Pharmaceutical giant Johnson & Johnson on Tuesday became the third drugmaker to sue the Biden administration over its new Medicare drug price negotiation program.

J&J joins a flurry of litigation challenging the Medicare drug price negotiation program, which is set to start this fall. Merck, Bristol Myers Squibb, the brand-drug lobby PhRMA, and the U.S. Chamber of Commerce have also filed suit. The negotiated prices would go into effect in 2026.

The company argued that it is entitled to sue because its blockbuster blood thinner drug Xarelto may be up for negotiation in the first round of ten drugs Medicare will examine, but that list is not set to be announced officially until Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on
Next article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

leisure time

The high cost of giving birth even with insurance

AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

UnitedHealth’s Optum accused of antitrust violations in California

EmanateHealthsuedUnitedHealth'sOptum,allegingtheinsurerpushedittoagreenottocompeteforprimarycarephys

Dobbs anniversary: the lost opportunity of abortion as health care

NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

Community addresses injustice for Long Island mothers

Inthethirdepisodeof“ColorCode,”wetakealookateffortsonLongIslandtoaddressracialdisparitiesinmaternala

Wikipedia

knowledge

leisure time

Community addresses injustice for Long Island mothers